Abstract:The security issue of human health is faced with dispiriting threats from multidrug-resistant bacteria infections induced by the abuse and misuse of antibiotics. Over decades, the antimicrobial peptides (AMPs) hold great promise as a viable alternative to treatment with antibiotics due to their peculiar antimicrobial mechanisms of action, broad-spectrum antimicrobial activity, lower drug residue, and ease of synthesis and modification. However, they universally express a series of disadvantages that hinder their potential application in the biomedical field (e.g., low bioavailability, poor protease resistance, and high cytotoxicity) and extremely waste the abundant resources of AMP database discovered over the decades. For all these reasons, the nanostructured antimicrobial peptides (Ns-AMPs), based on a variety of nanosystem modification, have made up for the deficiencies and pushed the development of novel AMP-based antimicrobial therapies. In this review, we provide an overview of the advantages of Ns-AMPs in improving therapeutic efficacy and biological stability, reducing side effects, and gaining the effect of organic targeting and drug controlled release. Then the different material categories of Ns-AMPs are described, including inorganic material nanosystems containing AMPs, organic material nanosystems containing AMPs, and self-assembled AMPs. Additionally, this review focuses on the Ns-AMPs for the effect of biological activities, with emphasis on antimicrobial activity, biosecurity, and biological stability. The "state-of-the-art" antimicrobial modes of Ns-AMPs, including controlled release of AMPs under a specific environment or intrinsic antimicrobial properties of Ns-AMPs, are also explicated. Finally, the perspectives and conclusions of the current research in this field are also summarized.

Design, Optimization, and Nanotechnology of Antimicrobial Peptides: from Exploration to Applications

Advances in the Delivery and Application of Antimicrobial Peptide-Based Nanomaterials

Antimicrobial Peptides: From Design to Clinical Application

Advances in Artificially Designed Antibacterial Active Antimicrobial Peptides.

Antimicrobial Peptides: Sustainable Application Informed by Evolutionary Constraints.

Biosynthesis, Bioactivity, Biotoxicity and Applications of Antimicrobial Peptides for Human Health

[Progress on the design and optimization of antimicrobial peptides]

Nanostructured Antimicrobial Peptides: Crucial Steps of Overcoming the Bottleneck for Clinics

Design methods for antimicrobial peptides with improved performance

Recent Advances and Challenges in Nanodelivery Systems for Antimicrobial Peptides (AMPs)

Advances in Antimicrobial Peptide Discovery via Machine Learning and Delivery via Nanotechnology

The Antimicrobial Peptides and Their Potential Clinical Applications.

Antimicrobial Peptides: Design, Chemical Synthesis, Activity Evaluation, and Application

Engineering Approaches for the Development of Antimicrobial Peptide-Based Antibiotics

Antimicrobial peptides for combating drug-resistant bacterial infections

Targeting Multidrug Resistance With Antimicrobial Peptide-Decorated Nanoparticles and Polymers

Dealing with MDR bacteria and biofilm in the post-antibiotic era: Application of antimicrobial peptides-based nano-formulation

Recent advances in design of antimicrobial peptides and polypeptides toward clinical translation

Chemical modifications to increase the therapeutic potential of antimicrobial peptides

Nanomedicine-based antimicrobial peptide delivery for bacterial infections: recent advances and future prospects

Antimicrobial Peptides: Diversity, Mechanism of Action and Strategies to Improve the Activity and Biocompatibility In Vivo